Tumor necrosis factor-α (TNF-α) blockers present a revolutionizing therapeutic choice for a number of inflammatory diseases such as Crohn’s disease (CD), ankylosing spondylitis (AS), and rheumatoid arthritis (RA). The gene discussed is TNF; the disease is Crohn disease.